A detailed history of Level Four Advisory Services, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Level Four Advisory Services, LLC holds 220,347 shares of PFE stock, worth $6.41 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
220,347
Previous 94,034 134.33%
Holding current value
$6.41 Million
Previous $2.61 Million 136.3%
% of portfolio
0.29%
Previous 0.14%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$25.26 - $29.6 $3.19 Million - $3.74 Million
126,313 Added 134.33%
220,347 $6.17 Million
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $7,145 - $8,205
276 Added 0.29%
94,034 $2.61 Million
Q4 2023

Feb 08, 2024

SELL
$26.13 - $33.94 $945,827 - $1.23 Million
-36,197 Reduced 27.85%
93,758 $2.7 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $757,837 - $885,836
-23,616 Reduced 15.38%
129,955 $4.31 Million
Q2 2023

Jul 10, 2023

BUY
$36.12 - $41.79 $80,222 - $92,815
2,221 Added 1.47%
153,571 $5.63 Million
Q1 2023

Jun 05, 2023

SELL
$39.39 - $51.28 $116,515 - $151,686
-2,958 Reduced 1.92%
151,350 $6.18 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $1.27 Million - $1.66 Million
30,369 Added 24.5%
154,308 $7.91 Million
Q3 2022

Nov 07, 2022

BUY
$43.76 - $53.42 $113,907 - $139,052
2,603 Added 2.15%
123,939 $5.42 Million
Q2 2022

Aug 08, 2022

BUY
$46.53 - $55.17 $305,702 - $362,466
6,570 Added 5.72%
121,336 $6.36 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $262,101 - $324,777
-5,729 Reduced 4.75%
114,766 $5.94 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $1.03 Million - $1.53 Million
24,926 Added 26.08%
120,495 $7.12 Million
Q3 2021

Oct 12, 2021

SELL
$39.25 - $50.42 $1.22 Million - $1.57 Million
-31,114 Reduced 24.56%
95,569 $4.11 Million
Q2 2021

Aug 09, 2021

BUY
$35.91 - $40.68 $312,273 - $353,753
8,696 Added 7.37%
126,683 $4.96 Million
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $105,292 - $118,748
-3,144 Reduced 2.6%
117,987 $4.28 Million
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $126,683 - $161,089
-3,785 Reduced 3.03%
121,131 $4.46 Million
Q3 2020

Nov 02, 2020

BUY
$31.75 - $37.25 $549,497 - $644,685
17,307 Added 16.08%
124,916 $4.58 Million
Q2 2020

Aug 17, 2020

BUY
$30.12 - $36.54 $3.24 Million - $3.93 Million
107,609 New
107,609 $3.51 Million
Q2 2020

Jul 27, 2020

SELL
$30.12 - $36.54 $3.07 Million - $3.72 Million
-101,808 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $181,101 - $258,753
-6,700 Reduced 6.17%
101,808 $3.32 Million
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $328,837 - $373,189
9,989 Added 10.14%
108,508 $12.4 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $298,160 - $386,627
9,177 Added 10.27%
98,519 $3.54 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $57,134 - $64,148
-1,545 Reduced 1.7%
89,342 $3.87 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $39,900 - $43,836
-1,064 Reduced 1.16%
90,887 $3.86 Million
Q4 2018

Feb 08, 2019

SELL
$38.47 - $43.86 $22,697 - $25,877
-590 Reduced 0.64%
91,951 $4.01 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $1.16 Million - $1.41 Million
-33,639 Reduced 26.66%
92,541 $4.08 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $79,778 - $85,052
-2,419 Reduced 1.88%
126,180 $4.58 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $113,057 - $131,161
3,543 Added 2.83%
128,599 $4.56 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $132,541 - $140,630
3,985 Added 3.29%
125,056 $4.53 Million
Q3 2017

Apr 03, 2018

BUY
$31.0 - $34.15 $202,213 - $222,760
6,523 Added 5.69%
121,071 $4.32 Million
Q3 2017

Nov 15, 2017

BUY
$31.0 - $34.15 $526,473 - $579,969
16,983 Added 17.41%
114,548 $4.12 Million
Q2 2017

Sep 20, 2017

SELL
N/A
-33,827 Reduced 25.75%
97,565 $3.34 Million
Q1 2017

Sep 20, 2017

BUY
N/A
131,392
131,392 $4.49 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Level Four Advisory Services, LLC Portfolio

Follow Level Four Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Level Four Advisory Services, LLC with notifications on news.